The legislation, promoted by Rep. Frank R. Wolf (R-Va.) and attached to a multi-department appropriations bill, passed last year with little notice. But this year the Food and Drug Administration, many drug makers and doctors who treat pain patients objected to renewing it, and the provision was stripped from the bill.
Opponents said the provision was an unwarranted intrusion by a law enforcement agency into the FDA’s drug-review system. Pain specialists also said the DEA reviews could jeopardize development of new drugs needed by patients with chronic pain.
Are people waking up? Realizing that the DEA has no business inserting itself in medical issues? I give a significant amount of credit for this to Radley Balko and others who have been reaching a lot of decision makers with their articles about the DEA’s abuses.
(Of course, there are still a lot of roles that we need to strip from the DEA.)